In addition, during clamp studies in patients with T2DM (28), a small early insulin response may actually be induced with high dose GIP infusions (whereas the second-phase response is completely absent), and this early response is, although smaller than that observed in controls, impaired to the same extent as the early response to GLP-1. This evidence concerns the gene GIP and type 2 diabetes mellitus.